LL-37 boosts immunosuppressive function of placenta-derived mesenchymal stromal cells

BACKGROUND: Although promising for graft-versus-host disease (GvHD) treatment, MSC therapy still faces important challenges. For instance, increasing MSC migratory capacity as well as potentializing immune response suppression are of interest. For GvHD management, preventing opportunistic infections...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Stem Cell Res Ther
Autors principals: Oliveira-Bravo, Martha, Sangiorgi, Bruno Braga, Schiavinato, Josiane Lilian dos Santos, Carvalho, Juliana Lott, Covas, Dimas Tadeu, Panepucci, Rodrigo Alexandre, Neves, Francisco de Assis Rocha, Franco, Octávio Luiz, Pereira, Rinaldo Wellerson, Saldanha-Araujo, Felipe
Format: Artigo
Idioma:Inglês
Publicat: BioMed Central 2016
Matèries:
Research
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC5203704/
https://ncbi.nlm.nih.gov/pubmed/28038684
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13287-016-0448-3
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars